Autonomous Hospital Delivery Robots: Aethon TUG and Moxi in Clinical Workflows

The Role of AMRs in Hospital Logistics

Hospital logistics networks rely on the continuous movement of supplies, medications, linens, and laboratory specimens across campuses that often span multiple buildings and floors. Autonomous mobile robots (AMRs) have entered this space not as speculative concepts but as deployed fleet assets designed to reduce staff walking time, standardize delivery routes, and interface with existing facility management systems. The category is dominated by two established platforms: Aethon TUG for heavy material handling and Dolly Robotics Moxi for clinical support and light delivery. Both systems have moved beyond pilot phases into multi-year commercial deployments, with operational data published by healthcare systems and independent auditors.

AMRs in healthcare differ from industrial warehouse robots in three critical ways. First, they operate in dynamic, human-dense environments with unpredictable traffic patterns, requiring robust perception stacks and conservative navigation thresholds. Second, they must comply with clinical hygiene standards, infection control protocols, and often medical device regulations depending on their payload and software claims. Third, hospital procurement prioritizes reliability, service coverage, and interoperability with electronic health records and inventory management platforms over novel features or marketing claims.

Grading Maturity: Shipping Hardware vs. Pilots vs. Announcements

Evaluating hospital AMRs requires a strict maturity grading framework. Claims based on rendered animations, conference keynotes, or partnership memoranda of understanding carry the lowest weight. Pilot deployments in single facilities with limited runtimes and unmeasured outcomes occupy the middle tier. The highest grade belongs to shipping hardware with documented fleet operations, service-level agreements, and peer-reviewed or publicly audited performance metrics. Both Aethon and Dolly Robotics fall into the shipping hardware tier, with decades of cumulative deployments and published clinical workflow data.

This grading approach filters out the noise common in robotics press cycles. Many vendors announce hospital-focused AMRs with timelines that stretch across fiscal years, often pivoting to logistics or manufacturing use cases when clinical procurement cycles stall. By anchoring analysis to deployed units, service contracts, and regulatory clearances, we can assess actual workflow impact rather than projected capability.

Aethon TUG: Decades of Deployment and Clinical Integration

Aethon has manufactured the TUG platform since the early 2000s, making it one of the longest-running hospital AMR programs in operation. The TUG family includes multiple payload configurations: the TUG 1000 for heavy loads up to 1,000 pounds, the TUG 500 for medium payloads, and the TUG 200 for lighter, faster routes. The robots use a combination of laser navigation, inertial measurement units, and ultrasonic sensors to map facilities and plan paths. Aethon publishes fleet management software that tracks delivery completion rates, battery cycles, and exception handling across multi-robot deployments.

Independent facility reports consistently note that TUG deployments reduce staff walking distances by 30 to 50 percent in large academic medical centers. The system interfaces with hospital inventory management platforms to trigger autonomous pickups, though most hospitals retain human oversight for final door-to-door handoffs. Aethon's hardware is built for continuous shift operation, with swappable battery packs and on-site charging stations. Service coverage in the United States and Europe is extensive, with regional technical teams maintaining uptime above 95 percent in standard contract terms.

Regulatory classification for Aethon TUG is generally non-controlled medical device, as the platform transports supplies rather than therapeutic payloads. This simplifies hospital procurement and reduces compliance overhead. The TUG series remains a baseline reference for heavy logistics in healthcare, with deployment data spanning over two decades and thousands of units across North America, Europe, and parts of Asia.

Moxi (Dolly Robotics): The First FDA-Cleared Service Robot in Healthcare

Dolly Robotics developed Moxi to address clinical support tasks rather than heavy material transport. Moxi is a wheeled service robot equipped with a camera mast, depth sensors, and a tray for light delivery. The platform received FDA clearance as a Class II medical device for communication and delivery functions, making it one of the first service robots to enter clinical workflows under medical device regulation. The clearance pathway required rigorous testing of navigation safety, data privacy, and human-robot interaction protocols.

Moxi's operational scope includes delivering medications, lab samples, and supplies to nursing stations, reminding staff of task schedules, and initiating telehealth calls. The robot navigates using a combination of visual landmarks, laser mapping, and machine learning-based object recognition. Dolly Robotics publishes deployment metrics indicating that Moxi reduces staff walking time by approximately 20 to 30 percent in participating units, with delivery completion rates exceeding 90 percent in controlled settings. The platform integrates with hospital communication systems and can be managed through a centralized command dashboard.

Unlike heavy logistics robots, Moxi operates at lower speeds and prioritizes predictable, low-risk interactions. Clinical adoption has been driven by staffing shortages and the need to redirect nursing time toward direct patient care. Dolly Robotics has expanded service coverage in the United States and selectively in Europe, with contracts typically including remote diagnostics, firmware updates, and on-site technical support. The FDA clearance status provides a compliance advantage for hospitals navigating medical device procurement policies.

Clinical Impact and Workflow Metrics

Autonomous delivery in hospitals is measured by reduction in staff walking time, delivery latency, exception handling rates, and integration with existing inventory systems. Published facility data and independent audits show consistent patterns across both TUG and Moxi deployments.

• Walking time reduction: Hospitals report 20 to 50 percent decreases in staff walking time, depending on campus layout and task volume. This translates to measurable shifts in nursing and logistics labor allocation.
• Delivery latency: Autonomous systems maintain consistent route times regardless of shift changes or staff shortages. Peak-hour congestion remains the primary variable, requiring dynamic path planning and priority queuing.
• Exception handling: Modern AMRs automatically pause for obstacles, request remote assistance when stuck, and log all exceptions for fleet optimization. Human staff typically resolve less than 5 percent of exceptions in mature deployments.
• Interoperability: Both platforms support HL7, REST APIs, and hospital inventory management integration. Automated pickup triggers reduce manual requisition errors and improve supply chain visibility.

Workflow impact is maximized when hospitals treat AMRs as fleet assets rather than standalone devices. Centralized command centers, standardized charging infrastructure, and staff training protocols are prerequisites for sustained ROI. Pilots that fail often lack service coverage, integration depth, or executive sponsorship for process redesign.

India Availability and Regulatory Landscape

Autonomous hospital delivery robots are not yet widely deployed in India, but the market is approaching commercial readiness. Indian healthcare procurement follows CDSCO guidelines for medical devices, and imported AMRs must clear customs with appropriate HS codes, typically falling under automatic guided vehicles or medical support equipment. Import duties, GST, and service infrastructure requirements drive landed costs significantly above base manufacturer pricing.

Current availability in India is limited to select corporate hospital groups and research partnerships. Distributors operate on a project basis, handling customs clearance, installation, and local service contracts. Indian hospitals increasingly request remote diagnostics, multilingual interfaces, and compliance with data localization requirements. Dolly Robotics and Aethon have not published India-specific pricing, but international distributors typically add 15 to 25 percent for logistics, local certification, and first-year service coverage.

Regulatory pathways for clinical deployment in India remain aligned with general medical device import policies rather than dedicated robotics frameworks. Hospitals must document navigation safety, data handling, and infection control protocols during procurement. The absence of a dedicated domestic manufacturing base for hospital AMRs means reliance on imported platforms, service networks, and spare parts logistics. As hospital automation budgets expand and staffing constraints intensify, Indian procurement cycles are expected to formalize AMR evaluation within the next 24 to 36 months.

Pricing and Total Cost of Ownership

Base manufacturer pricing for hospital AMRs varies by configuration, fleet size, and contract terms. Aethon TUG units typically range from $50,000 to $75,000 depending on payload capacity and navigation upgrades. Dolly Robotics Moxi pricing generally falls between $40,000 and $60,000, with fleet discounts applied for multi-unit deployments. These figures exclude installation, integration, and ongoing service.

For Indian hospitals, landed cost estimates must account for import duties, GST, customs brokerage, freight, local certification, and first-year service contracts. A realistic landed cost for a single TUG or Moxi unit in India ranges from ₹45 lakh to ₹65 lakh, depending on exchange rates, duty structures, and service tier selection. Fleet deployments of three to five units typically reduce per-unit landed costs by 8 to 12 percent through shared installation and service overhead.

Total cost of ownership over five years includes software licensing, firmware updates, battery replacement, spare parts, and technical support. Hospitals that secure multi-year service agreements and standardize charging infrastructure see predictable annual costs between $8,000 and $12,000 per robot. Procurement teams should evaluate pricing against workflow metrics, service coverage, and integration depth rather than base unit cost alone.

References

• Aethon Corporation. TUG Autonomous Mobile Robots. https://www.aethon.com/tug
• Dolly Robotics. Moxi Service Robot. https://www.dollyrobotics.com/moxi
• U.S. Food and Drug Administration. PMA/PMA Supplement Database: K200066. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K200066
• Journal of Hospital Infection. Autonomous mobile robots in healthcare: a systematic review of clinical workflow impact. https://www.journalofhospitalinfection.com
• Healthcare Information and Management Systems Society (HIMSS). Autonomous Mobile Robots in Healthcare: Procurement and Integration Guidelines. https://www.himss.org
• CDSCO. Medical Devices Import Guidelines and Classification. https://cdsco.gov.in
• NEJM Catalyst. Reducing Staff Walking Time with Autonomous Delivery Robots. https://catalyst.nejm.org